123 related articles for article (PubMed ID: 18502680)
1. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models.
Kruglov AA; Kuchmiy A; Grivennikov SI; Tumanov AV; Kuprash DV; Nedospasov SA
Cytokine Growth Factor Rev; 2008; 19(3-4):231-44. PubMed ID: 18502680
[TBL] [Abstract][Full Text] [Related]
2. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis.
Douni E; Akassoglou K; Alexopoulou L; Georgopoulos S; Haralambous S; Hill S; Kassiotis G; Kontoyiannis D; Pasparakis M; Plows D; Probert L; Kollias G
J Inflamm; 1995-1996; 47(1-2):27-38. PubMed ID: 8913927
[TBL] [Abstract][Full Text] [Related]
3. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).
Dick AD; Forrester JV; Liversidge J; Cope AP
Prog Retin Eye Res; 2004 Nov; 23(6):617-37. PubMed ID: 15388077
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha in the nucleus pulposus mediates radicular pain, but not increase of inflammatory peptide, associated with nerve damage in mice.
Yamashita M; Ohtori S; Koshi T; Inoue G; Yamauchi K; Suzuki M; Takahashi K
Spine (Phila Pa 1976); 2008 Aug; 33(17):1836-42. PubMed ID: 18670336
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor and the consequences of its ablation in vivo.
Efimov GA; Kruglov AA; Tillib SV; Kuprash DV; Nedospasov SA
Mol Immunol; 2009 Nov; 47(1):19-27. PubMed ID: 19230974
[TBL] [Abstract][Full Text] [Related]
6. Current and future approaches using genetically modified mice in endocrine research.
Davey RA; MacLean HE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E429-38. PubMed ID: 16684850
[TBL] [Abstract][Full Text] [Related]
7. [Transgenic mice in basic research].
Gassmann M; Hennet T; Bauer C
Schweiz Arch Tierheilkd; 1998; 140(5):198-204. PubMed ID: 9617206
[TBL] [Abstract][Full Text] [Related]
8. Teaching molecular genetics: chapter 2-Transgenesis and gene targeting: mouse models to study gene function and expression.
Claij N; Peters DJ
Pediatr Nephrol; 2006 Mar; 21(3):318-23. PubMed ID: 16395602
[TBL] [Abstract][Full Text] [Related]
9. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury.
Berger S; Savitz SI; Nijhawan S; Singh M; David J; Rosenbaum PS; Rosenbaum DM
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3605-10. PubMed ID: 18660426
[TBL] [Abstract][Full Text] [Related]
10. Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice.
Winsauer C; Kruglov AA; Chashchina AA; Drutskaya MS; Nedospasov SA
Cytokine Growth Factor Rev; 2014 Apr; 25(2):115-23. PubMed ID: 24405806
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell-based assay for examining the expression of tumor necrosis factor alpha (TNF-alpha) gene.
Chen Q; Zhao Y; Cheng Z; Xu Y; Yu C
Appl Microbiol Biotechnol; 2008 Aug; 80(2):357-63. PubMed ID: 18560829
[TBL] [Abstract][Full Text] [Related]
12. The effects of TNF deficiency on age-related cognitive performance.
McAfoose J; Koerner H; Baune BT
Psychoneuroendocrinology; 2009 May; 34(4):615-9. PubMed ID: 19028017
[TBL] [Abstract][Full Text] [Related]
13. Influence of antisense oligonucleotides targeting tumor necrosis factor-alpha on experimental herpetic-induced chorioretinitis of mouse eye.
Mei H; Xing Y; Yang J; Wang A; Xu Y; Heiligenhaus A
Pathobiology; 2009; 76(1):45-50. PubMed ID: 19188750
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
[TBL] [Abstract][Full Text] [Related]
16. Gene-knockout mice in malaria research: useful or misleading?
Hernandez-Valladares M; Naessens J; Iraqi FA
Trends Parasitol; 2007 Nov; 23(11):522-6. PubMed ID: 17951110
[TBL] [Abstract][Full Text] [Related]
17. Factor IX: Insights from knock-out and genetically engineered mice.
Monahan PE
Thromb Haemost; 2008 Oct; 100(4):563-75. PubMed ID: 18841277
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of interaction of tumor necrosis factor (TNF-alpha) of macroorganism with the Salmonella enterica cells (ser. Typhimurium)].
Romanova IuM; Tomova AS; Shingarova LN; Lunin VG; Kariagina AS; Lupu IP; Gintsburg AL
Mol Gen Mikrobiol Virusol; 2008; (4):18-22. PubMed ID: 19172874
[TBL] [Abstract][Full Text] [Related]
19. Knockin animal models of inherited arrhythmogenic diseases: what have we learned from them?
Nilles KM; London B
J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1117-25. PubMed ID: 17573834
[TBL] [Abstract][Full Text] [Related]
20. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
Murai M; Tsuji F; Nose M; Seki I; Oki K; Setoguchi C; Suhara H; Sasano M; Aono H
Eur J Pharmacol; 2008 Jul; 588(2-3):309-15. PubMed ID: 18508045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
